Topics

Allergan pays $750M to rid itself of Namenda antitrust charges

07:39 EDT 28 Oct 2019 | BioPharmaDive

A class action suit followed the New York attorney general in claiming the big pharma tried to delay generic competition to its Alzheimer's drug

Original Article: Allergan pays $750M to rid itself of Namenda antitrust charges

NEXT ARTICLE

More From BioPortfolio on "Allergan pays $750M to rid itself of Namenda antitrust charges"

Quick Search

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...